Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Trying to Resolve a Dispute Over the Best Way to Diagnose Cervical Neoplasia in a Developing Country
Link ID 2294
Title Trying to Resolve a Dispute Over the Best Way to Diagnose Cervical Neoplasia in a Developing Country
Url http://www.medscape.com/viewarticle/567881?src=rss
Description How do you resolve a dispute over the best method to diagnose cervical neoplasia in a developing country?
The Medscape Journal of Medicine
Category Articles > Allergy and Clinical Immunology
Keywords
Date Jan 11, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Allergy and Clinical Immunology
1. Neonatal Screening for Severe Combined Immune Deficiency
  An update on the latest developments in newborn screening for severe combined immunodeficiency.
Current Opinion in Allergy and Clinical Immunology
Category:   Articles > Allergy and Clinical Immunology


2. Failed HIV Vaccine May Have Increased Vulnerability to Infection
  It is possible that the delivery vehicle for a recently discontinued investigational HIV vaccine increased susceptibility to HIV infection among the volunteers who received the vaccine, the researchers said Wednesday at a press conference in Seattle, Washington. Reuters Health Information
Category:   Articles > Allergy and Clinical Immunology


3. Clinicians Must Reinvent the Medical Record to Stimulate the Adoption of Electronic Medical Records
  Blake Lesselroth, MD, MBI, Assistant Professor of Medicine and Medical Informatics, Portland VA Medical Center, Portland, Oregon, proposes a radical reform for electronic medical records.
The Medscape Journal of Medicine
Category:   Articles > Allergy and Clinical Immunology


4. Encouraging Phase 2b Results With Oral Laquinimod in MS
  Results of a phase 2b trial of laquinimod, an investigational oral treatment for MS, showed the higher dose of 0.6 mg/day was well tolerated and significantly reduced disease activity on MRI. Phase 3 trials are under way. Medscape Medical News
Category:   Articles > Allergy and Clinical Immunology


5. A Question of Priorities in the Treatment of Breast Cancer
  M. Carolina Hinestrosa, MA, MPH, Executive Vice President, Programs and Planning, National Breast Cancer Coalition, Washington, DC, gives a cautionary challenge on proper use of ESAs.
The Medscape Journal of Medicine
Category:   Articles > Allergy and Clinical Immunology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS